Medpace Holdings, Inc. Long-Term Debt, Maturity, Year Five
Medpace Holdings, Inc. (MEDP) had Long-Term Debt, Maturity, Year Five of $129.00 million as of 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2017-10-31
- 2017-09-30: Long-Term Debt, Maturity, Year Five $129.00M.
- 2017-06-30: Long-Term Debt, Maturity, Year Five $99.00M.
- 2017-03-31: Long-Term Debt, Maturity, Year Five $99.00M.
- 2016-12-31: Long-Term Debt, Maturity, Year Five $99.00M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2017-09-30 | $129.00M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $99.00M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $99.00M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $99.00M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |